IRPCM

International Research Programme on Comparative Mycoplasmology

User Tools

Site Tools


teams:chemotherapy:start

Chemotherapy of Mycoplasma Infections

  • Team Leader: Florence Tardy (France)
  • Vision of the IRPCM chemotherapy group:
    • Ascertain and reduce antimicrobial resistance levels in mollicutes to protect global human and animals for the future
    • Coordinating international agreed standards for MIC of mollicute species
    • Mapping global resistance of mollicutes of human and veterinary importance
    • Reducing unnecessary use of antimicrobials and promoting good stewardship
    • Understanding the molecular mechanisms of resistance
    • Evaluation of new and alternative agents
  • Current Goals:
    • To standardize veterinary mycoplasma antimicrobial sensitivity testing, including control strains and methodology like it was done for human mycoplasmas.
    • To continue work on molecular determinants of antimicrobial resistance
    • Identifying breakpoints
    • Epidemiological surveillance
    • Monitoring of antimicrobial resistance
    • Development of the molecular assay to track antimicrobial resistance in the real-time
    • Molecular typing of strains with different susceptibility
    • Evaluation of new and alternative chemotherapeutic agents
teams/chemotherapy/start.txt · Last modified: 2023/08/03 16:32 by chk